4.4 Article

Allostery and population shift in drug discovery

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 10, Issue 6, Pages 715-722

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2010.09.002

Keywords

-

Funding

  1. TUBITAK [109T343, 109E207]
  2. National Cancer Institute National Institutes of Health [HHSN261200800001E]
  3. NIH National Cancer Institute Center for Cancer Research

Ask authors/readers for more resources

Proteins can exist in a large number of conformations around their native states that can be characterized by an energy landscape The landscape illustrates individual valleys, which are the conformational substates From the functional standpoint there are two key points first, all functionally relevant substates pre-exist, and second the landscape is dynamic and the relative populations of the substates will change following allosteric events Allosteric events perturb the structure and the energetic strain propagates and shifts the population This can lead to changes in the shapes and properties of target binding sites Here we present an overview of dynamic conformational ensembles focusing on allosteric events in signaling We propose that combining equilibrium fluctuation concepts with genomic screens could help drug discovery

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available